{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T20:41:24Z","timestamp":1793911284107,"version":"4.8.0"},"reference-count":94,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.ijbiomac.2025.145987","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T11:04:04Z","timestamp":1752577444000},"page":"145987","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"P3","title":["A comprehensive review on natural polysaccharides based in situ gels for nasal drug delivery"],"prefix":"10.1016","volume":"320","author":[{"given":"Shubham","family":"Sonawane","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hemant","family":"Shelke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smita","family":"Bonde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2025.145987_bb0005","first-page":"1","article-title":"In situ nasal gel drug delivery: a novel approach for brain targeting through the mucosal membrane","author":"Kaur","year":"2015","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"10.1016\/j.ijbiomac.2025.145987_bb0010","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s40005-023-00626-x","article-title":"Polysaccharide-based platforms for nasal delivery: design, features, and perspectives","volume":"53","author":"Elmowafy","year":"2023","journal-title":"J. Pharm. Investig."},{"key":"10.1016\/j.ijbiomac.2025.145987_bb0015","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/S1359-6446(02)02529-1","article-title":"Nasal drug delivery: new developments and strategies","volume":"7","author":"Illum","year":"2002","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ijbiomac.2025.145987_bb0020","series-title":"Nasal Drug Delivery","first-page":"189","article-title":"Novel Mucoadhesive Polymers for Nasal Drug Delivery","author":"Djekic","year":"2023"},{"key":"10.1016\/j.ijbiomac.2025.145987_bb0025","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nrd.2015.21","article-title":"From blood\u2013brain barrier to blood\u2013brain interface: new opportunities for CNS drug delivery","volume":"15","author":"Banks","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ijbiomac.2025.145987_bb0030","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.addr.2011.11.010","article-title":"Modern methods for delivery of drugs across the blood\u2013brain barrier","volume":"64","author":"Chen","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijbiomac.2025.145987_bb0035","series-title":"Drug Delivery Strategies in Neurological Disorders: Challenges and Opportunities","first-page":"405","article-title":"Nose-to-brain drug delivery strategies for the treatment of neurological disorders","author":"D.Bhatane","year":"2023"},{"key":"10.1016\/j.ijbiomac.2025.145987_bb0040","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s13346-012-0108-9","article-title":"Nasal drug delivery devices: characteristics and performance in a clinical perspective\u2014a review","volume":"3","author":"Djupesland","year":"2013","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ijbiomac.2025.145987_bb0045","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s13346-021-00940-7","article-title":"Intranasal drug delivery for treatment of Alzheimer's disease","volume":"11","author":"Fonseca","year":"2021","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ijbiomac.2025.145987_bb0050","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1002\/jps.21924","article-title":"Intranasal delivery to the central nervous system: mechanisms and experimental considerations","volume":"99","author":"Dhuria","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijbiomac.2025.145987_bb0055","doi-asserted-by":"crossref","first-page":"13077","DOI":"10.1007\/s12274-023-6026-y","article-title":"Intranasal administration nanosystems for brain-targeted drug delivery","volume":"16","author":"Jiang","year":"2023","journal-title":"Nano Res"},{"key":"10.1016\/j.ijbiomac.2025.145987_bb0060","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15102508","article-title":"Polysaccharide-based nanogels to overcome mucus, skin, cornea, and blood-brain barriers: a review","volume":"15","author":"Wang","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijbiomac.2025.145987_bb0065","series-title":"Polysaccharide Carriers for Drug Delivery","first-page":"615","article-title":"In situ polysaccharide-based gels for topical drug delivery applications","author":"Nayak","year":"2019"},{"key":"10.1016\/j.ijbiomac.2025.145987_bb0070","doi-asserted-by":"crossref","DOI":"10.2147\/DDDT.S87368","article-title":"A novel in situ gel base of deacetylase gellan gum for sustained ophthalmic drug delivery of ketotifen: in vitro and in vivo evaluation","author":"Li","year":"2015","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.ijbiomac.2025.145987_bb0075","doi-asserted-by":"crossref","first-page":"395","DOI":"10.36233\/0507-4088-139","article-title":"<i>In situ<\/i> gels as a modern method of intranasal vaccine delivery","volume":"67","author":"Bakhrushina","year":"2022","journal-title":"Probl. Virol."},{"key":"10.1016\/j.ijbiomac.2025.145987_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.122630","article-title":"Optimising nasal powder drug delivery \u2013 characterisation of the effect of excipients on drug absorption","volume":"633","author":"Trenkel","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2025.145987_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.123819","article-title":"In-situ gel: A smart carrier for drug delivery","volume":"652","author":"Garg","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2025.145987_bb0090","series-title":"Direct Nose-to-Brain Drug Delivery","first-page":"115","article-title":"Mucoadhesion as a strategy to enhance the direct nose-to-brain drug delivery","author":"Patil","year":"2021"},{"key":"10.1016\/j.ijbiomac.2025.145987_bb0095","doi-asserted-by":"crossref","first-page":"215","DOI":"10.4103\/2231-4040.90876","article-title":"A review on mucoadhesive polymer used in nasal drug delivery system","volume":"2","author":"Chaturvedi","year":"2011","journal-title":"J. Adv. Pharm. Technol. Res."},{"key":"10.1016\/j.ijbiomac.2025.145987_bb0100","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1023\/A:1015830907632","article-title":"The nasal mucociliary clearance: relevance to nasal drug delivery","author":"Schipper","year":"1991","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijbiomac.2025.145987_bb0105","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.ejpb.2008.09.028","article-title":"Mucoadhesive polymeric platforms for controlled drug delivery","volume":"71","author":"Andrews","year":"2009","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijbiomac.2025.145987_bb0110","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ejpb.2017.10.008","article-title":"In situ mucoadhesive-thermosensitive liposomal gel as a novel vehicle for nasal extended delivery of opiorphin","volume":"122","author":"Mura","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijbiomac.2025.145987_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120250","article-title":"Nose-to-brain delivery of disulfiram nanoemulsion in situ gel formulation for glioblastoma targeting therapy","volume":"597","author":"Qu","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2025.145987_bb0120","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jconrel.2023.04.021","article-title":"Intranasal nanotherapeutics for brain targeting and clinical studies in Parkinson\u2019s disease","volume":"358","author":"Saha","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2025.145987_bb0125","doi-asserted-by":"crossref","DOI":"10.1007\/s40199-024-00543-w","article-title":"Recent opportunities and application of gellan gum based drug delivery system for intranasal route","author":"Garg","year":"2024","journal-title":"DARU Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.ijbiomac.2025.145987_bb0130","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0378-5173(93)90358-M","article-title":"Intranasal absorption of angiopeptin: in vitro study of absorption and enzymatic degradation","volume":"99","author":"J\u00f8rgensen","year":"1993","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2025.145987_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120994","article-title":"Progress in nasal drug delivery systems","volume":"607","author":"Laffleur","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2025.145987_bb0140","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1007\/s13346-024-01558-1","article-title":"Insulin delivery to the brain via the nasal route: unraveling the potential for Alzheimer's disease therapy","volume":"14","author":"Wong","year":"2024","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ijbiomac.2025.145987_bb0145","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics11030113","article-title":"Strategies to enhance drug absorption via nasal and pulmonary routes","volume":"11","author":"Ghadiri","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijbiomac.2025.145987_bb0150","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jconrel.2023.04.021","article-title":"Intranasal nanotherapeutics for brain targeting and clinical studies in Parkinson\u2019s disease","volume":"358","author":"Saha","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2025.145987_bb0155","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.drudis.2015.10.016","article-title":"Smart materials: in situ gel-forming systems for nasal delivery","volume":"21","author":"Karavasili","year":"2016","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ijbiomac.2025.145987_bb0160","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14091870","article-title":"Nose-to-brain delivery of therapeutic peptides as nasal aerosols","volume":"14","author":"Alabsi","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijbiomac.2025.145987_bb0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2007.03.025","article-title":"Intranasal delivery: physicochemical and therapeutic aspects","volume":"337","author":"Costantino","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2025.145987_bb0170","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15082119","article-title":"Optimizing absorption for intranasal delivery of drugs targeting the central nervous system using alkylsaccharide permeation enhancers","volume":"15","author":"Madden","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijbiomac.2025.145987_bb0175","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1159\/000080183","article-title":"Effects of preservatives in nasal formulations on the mucosal integrity: an Electron microscopic study","volume":"72","author":"Lebe","year":"2004","journal-title":"Pharmacology"},{"key":"10.1016\/j.ijbiomac.2025.145987_bb0180","article-title":"The nose as a route for therapy: part 1. Pharmacotherapy, Frontiers","volume":"2","author":"Cingi","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.ijbiomac.2025.145987_bb0185","series-title":"Nasal Drug Delivery","first-page":"189","article-title":"Novel Mucoadhesive Polymers for Nasal Drug Delivery","author":"Djekic","year":"2023"},{"key":"10.1016\/j.ijbiomac.2025.145987_bb0190","first-page":"1","article-title":"In situ nasal gel drug delivery: a novel approach for brain targeting through the mucosal membrane","author":"Kaur","year":"2015","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"10.1016\/j.ijbiomac.2025.145987_bb0195","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s40005-022-00589-5","article-title":"Drug delivery to the brain via the nasal route of administration: exploration of key targets and major consideration factors","volume":"53","author":"Jeong","year":"2023","journal-title":"J. Pharm. Investig."},{"key":"10.1016\/j.ijbiomac.2025.145987_bb0200","series-title":"The Chemistry and Physics of Aerogels","first-page":"92","article-title":"Gelation","author":"Ratke","year":"2021"},{"key":"10.1016\/j.ijbiomac.2025.145987_bb0205","doi-asserted-by":"crossref","DOI":"10.1002\/masy.202300153","article-title":"Exploring the transformative potential of in situ gels: an overview of thermosensitive and pH-sensitive gel Systems for Biomedical Applications","volume":"413","author":"Patil","year":"2024","journal-title":"Macromol. Symp."},{"key":"10.1016\/j.ijbiomac.2025.145987_bb0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2021\/1546798","article-title":"Fabrication of a thermosensitive in situ gel Nanoemulsion for nose to brain delivery of Temozolomide","volume":"2021","author":"Bayanati","year":"2021","journal-title":"J. Nanomater."},{"key":"10.1016\/j.ijbiomac.2025.145987_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124814","article-title":"Dihydroquercetin nanoparticles nasal gel is a promising formulation for amelioration of Alzheimer\u2019s disease","volume":"666","author":"Abou-Taleb","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2025.145987_bb0220","doi-asserted-by":"crossref","DOI":"10.1002\/masy.202300153","article-title":"Exploring the transformative potential of in situ gels: an overview of thermosensitive and pH-sensitive gel Systems for Biomedical Applications","volume":"413","author":"Patil","year":"2024","journal-title":"Macromol. Symp."},{"key":"10.1016\/j.ijbiomac.2025.145987_bb0225","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ijbiomac.2016.02.044","article-title":"Ion activated in situ gel of gellan gum containing salbutamol sulphate for nasal administration","volume":"87","author":"Salunke","year":"2016","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2025.145987_bb0230","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3109\/10717544.2014.891272","article-title":"Poloxamer-based in situ hydrogels for controlled delivery of hydrophilic macromolecules after intramuscular injection in rats","volume":"22","author":"Zhang","year":"2015","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ijbiomac.2025.145987_bb0235","first-page":"1","article-title":"In situ nasal gel drug delivery: a novel approach for brain targeting through the mucosal membrane","author":"Kaur","year":"2015","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"10.1016\/j.ijbiomac.2025.145987_bb0240","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ejpb.2017.10.008","article-title":"In situ mucoadhesive-thermosensitive liposomal gel as a novel vehicle for nasal extended delivery of opiorphin","volume":"122","author":"Mura","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijbiomac.2025.145987_bb0245","doi-asserted-by":"crossref","DOI":"10.1002\/mba2.55","article-title":"Recent progress in thermosensitive hydrogels and their applications in drug delivery area","volume":"2","author":"Khan","year":"2023","journal-title":"MedComm \u2013 Biomaterials and Applications"},{"key":"10.1016\/j.ijbiomac.2025.145987_bb0250","doi-asserted-by":"crossref","DOI":"10.1007\/s10965-019-1771-z","article-title":"Thermosensitive hydrogel-based drug delivery system for sustained drug release","volume":"26","author":"Patel","year":"2019","journal-title":"J. Polym. Res."},{"key":"10.1016\/j.ijbiomac.2025.145987_bb0255","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ijpharm.2011.03.042","article-title":"Comparison of ion-activated in situ gelling systems for ocular drug delivery. Part 1: physicochemical characterisation and in vitro release","volume":"411","author":"Rupenthal","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2025.145987_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.123819","article-title":"In-situ gel: A smart carrier for drug delivery","volume":"652","author":"Garg","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2025.145987_bb0265","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1080\/713840402","article-title":"Ion-activated in situ gelling Systems for Sustained Ophthalmic Delivery of ciprofloxacin hydrochloride","volume":"10","author":"Balasubramaniam","year":"2003","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ijbiomac.2025.145987_bb0270","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3109\/10717544.2013.849778","article-title":"Development of in situ gel for nasal delivery: design, optimization, in vitro and in vivo evaluation","volume":"21","author":"Galgatte","year":"2014","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ijbiomac.2025.145987_bb0275","doi-asserted-by":"crossref","DOI":"10.3390\/polym16050685","article-title":"Intranasal ion-triggered in situ delivery system of virus-like particles: development using the quality by design approach","volume":"16","author":"Bakhrushina","year":"2024","journal-title":"Polymers (Basel)"},{"key":"10.1016\/j.ijbiomac.2025.145987_bb0280","doi-asserted-by":"crossref","DOI":"10.3390\/nano7110399","article-title":"Synthesis and swelling behavior of pH-sensitive semi-IPN superabsorbent hydrogels based on poly(acrylic acid) reinforced with cellulose nanocrystals","volume":"7","author":"Lim","year":"2017","journal-title":"Nanomaterials"},{"key":"10.1016\/j.ijbiomac.2025.145987_bb0285","first-page":"416","article-title":"Development and evaluation of a pH triggered in situ ocular gel of brimonidine tartrate","volume":"24","author":"Bharath","year":"2020","journal-title":"J. Res. Pharm."},{"key":"10.1016\/j.ijbiomac.2025.145987_bb0290","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1208\/s12249-017-0844-8","article-title":"Development and evaluation of pH-responsive Cyclodextrin-based in situ gel of Paliperidone for intranasal delivery","volume":"19","author":"Sherje","year":"2018","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijbiomac.2025.145987_bb0295","first-page":"1","article-title":"Research progress of in-situ gelling ophthalmic drug delivery system","volume":"14","author":"Wu","year":"2019","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.ijbiomac.2025.145987_bb0300","author":"Khot"},{"key":"10.1016\/j.ijbiomac.2025.145987_bb0305","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202370169","article-title":"Enzyme-triggered intestine-specific targeting adhesive platform for universal Oral drug delivery","volume":"12","author":"Li","year":"2023","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.ijbiomac.2025.145987_bb0310","doi-asserted-by":"crossref","DOI":"10.1186\/s42269-023-01123-9","article-title":"Revolutionizing ocular drug delivery: recent advancements in in situ gel technology","volume":"47","author":"Paul","year":"2023","journal-title":"Bull. Natl. Res. Cent."},{"key":"10.1016\/j.ijbiomac.2025.145987_bb0315","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4103\/2231-4040.107495","article-title":"Nanoparticles laden in situ gelling system for ocular drug targeting","volume":"4","author":"Kumar","year":"2013","journal-title":"J. Adv. Pharm. Technol. Res."},{"key":"10.1016\/j.ijbiomac.2025.145987_bb0320","series-title":"Silva, Thermosensitive Nasal in Situ Gels of Lipid-Based Nanosystems to Improve the Treatment of Alzheimer\u2019s Disease, in: The 1st International Electronic Conference on Pharmaceutics","first-page":"37","article-title":"A.C","author":"Cunha","year":"2020"},{"key":"10.1016\/j.ijbiomac.2025.145987_bb0325","doi-asserted-by":"crossref","first-page":"10435","DOI":"10.2147\/IJN.S265659","article-title":"Nose-to-brain delivery by Nanosuspensions-based in situ gel for Breviscapine","volume":"15","author":"Chen","year":"2020","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ijbiomac.2025.145987_bb0330","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.5958\/0974-360X.2017.00328.6","article-title":"Review on in-situ nasal gel drug delivery system","volume":"10","author":"Saudagar","year":"2017","journal-title":"Res J Pharm Technol"},{"key":"10.1016\/j.ijbiomac.2025.145987_bb0335","first-page":"1875","article-title":"Nasal in situ gels as a drug delivery system: an overview of literature and clinical studies","volume":"27","author":"\u00c7elik","year":"2023","journal-title":"J. Res. Pharm."},{"key":"10.1016\/j.ijbiomac.2025.145987_bb0340","doi-asserted-by":"crossref","DOI":"10.2147\/DDDT.S235004","article-title":"Development and Evaluation of in-situ Nasal Gel Formulations of Nanosized Transferosomal Sumatriptan: Design, Optimization, in vitro and in vivo Evaluation<\/p>","volume":"Volume 13","author":"Omar","year":"2019","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.ijbiomac.2025.145987_bb0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpb.2025.114743","article-title":"Ceftriaxone-loaded albumin-based nanoparticles incorporated into in situ ionic sensitive nasal gels: development, characterization, and nasal drug deposition studies","volume":"212","author":"Mardikasari","year":"2025","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijbiomac.2025.145987_bb0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.nexres.2025.100234","article-title":"Quetiapine fumarate-loaded mixed micelles in nasal in-situ gels: enhancing efficacy for schizophrenia management","volume":"2","author":"Puranik","year":"2025","journal-title":"Next Research"},{"key":"10.1016\/j.ijbiomac.2025.145987_bb0355","article-title":"Nanostructured cubosomal in situ nasal gel for the treatment of migraine","volume":"87","author":"Tekade","year":"2023","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ijbiomac.2025.145987_bb0360","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jconrel.2020.07.044","article-title":"Stimuli-responsive in situ gelling system for nose-to-brain drug delivery","volume":"327","author":"Agrawal","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2025.145987_bb0365","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.drudis.2015.10.016","article-title":"Smart materials: in situ gel-forming systems for nasal delivery","volume":"21","author":"Karavasili","year":"2016","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ijbiomac.2025.145987_bb0370","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/847547","article-title":"Formulation and evaluation of thermosensitive biogels for nose to brain delivery of doxepin","volume":"2014","author":"Naik","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.ijbiomac.2025.145987_bb0375","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.134385","article-title":"In situ-gelling hydrophobized starch nanoparticle-based nanoparticle network hydrogels for the effective delivery of intranasal olanzapine to treat brain disorders","volume":"277","author":"Lofts","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2025.145987_bb0380","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.1016\/j.xphs.2017.08.024","article-title":"Nose to brain delivery of Rivastigmine by in situ gelling cationic nanostructured lipid carriers: enhanced brain distribution and pharmacodynamics","volume":"106","author":"Wavikar","year":"2017","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijbiomac.2025.145987_bb0385","doi-asserted-by":"crossref","first-page":"6031","DOI":"10.1016\/j.biomaterials.2010.04.009","article-title":"Tyrosine-based rivastigmine-loaded organogels in the treatment of Alzheimer\u2019s disease","volume":"31","author":"Bastiat","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijbiomac.2025.145987_bb0390","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3109\/10611860903386938","article-title":"Formulation of intranasal mucoadhesive temperature-mediated in situ gel containing ropinirole and evaluation of brain targeting efficiency in rats","volume":"18","author":"Khan","year":"2010","journal-title":"J. Drug Target."},{"key":"10.1016\/j.ijbiomac.2025.145987_bb0395","doi-asserted-by":"crossref","first-page":"319","DOI":"10.5055\/jom.2010.0029","article-title":"Long-term safety, tolerability, and consistency of effect of fentanyl pectin nasal spray for breakthrough cancer pain in opioid-tolerant patients","volume":"6","author":"Portenoy","year":"2018","journal-title":"J. Opioid Manag."},{"key":"10.1016\/j.ijbiomac.2025.145987_bb0400","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ijpharm.2019.04.015","article-title":"Innovative sprayable in situ gelling fluticasone suspension: development and optimization of nasal deposition","volume":"563","author":"Ni\u017ei\u0107","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2025.145987_bb0405","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3109\/08982104.2015.1132232","article-title":"Poloxamer 407-based intranasal thermoreversible gel of zolmitriptan-loaded nanoethosomes: formulation, optimization, evaluation and permeation studies","volume":"26","author":"Shelke","year":"2016","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.ijbiomac.2025.145987_bb0410","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.colsurfb.2016.08.011","article-title":"Fabrication of an ionic-sensitive in situ gel loaded with resveratrol nanosuspensions intended for direct nose-to-brain delivery","volume":"147","author":"Hao","year":"2016","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.ijbiomac.2025.145987_bb0415","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0189478","article-title":"A mucoadhesive, thermoreversible in situ nasal gel of geniposide for neurodegenerative diseases","volume":"12","author":"Wang","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ijbiomac.2025.145987_bb0420","doi-asserted-by":"crossref","DOI":"10.3390\/nano9020147","article-title":"An available strategy for nasal brain transport of nanocomposite based on PAMAM dendrimers via in situ gel","volume":"9","author":"Xie","year":"2019","journal-title":"Nanomaterials"},{"key":"10.1016\/j.ijbiomac.2025.145987_bb0425","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ijpharm.2019.01.044","article-title":"In situ thermo-co-electroresponsive mucogel for controlled release of bioactive agent","volume":"559","author":"Akilo","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2025.145987_bb0430","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.123345","article-title":"In situ hydrogel containing diazepam-loaded nanostructured lipid carriers (DZP-NLC) for nose-to-brain delivery: development, characterization and deposition studies in a 3D-printed human nasal cavity model","volume":"644","author":"Pina Costa","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2025.145987_bb0435","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.134908","article-title":"A thermosensitive chitosan hydrogel: an attempt for the nasal delivery of dimethyl fumarate","volume":"278","author":"Nieto Gonz\u00e1lez","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2025.145987_bb0440","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1007\/s13346-018-0540-6","article-title":"In situ nanostructured hydrogel of resveratrol for brain targeting: in vitro-in vivo characterization","volume":"8","author":"Rajput","year":"2018","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ijbiomac.2025.145987_bb0445","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3109\/10717544.2013.849778","article-title":"Development of in situ gel for nasal delivery: design, optimization, in vitro and in vivo evaluation","volume":"21","author":"Galgatte","year":"2014","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ijbiomac.2025.145987_bb0450","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1080\/08982104.2018.1552703","article-title":"Nanostructured cubosomes in an in situ nasal gel system: an alternative approach for the controlled delivery of donepezil HCl to brain","volume":"29","author":"Patil","year":"2019","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.ijbiomac.2025.145987_bb0455","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1745-7254.2007.00486.x","article-title":"Drug brain distribution following intranasal administration of Huperzine A in situ gel in rats","volume":"28","author":"Zhao","year":"2007","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ijbiomac.2025.145987_bb0460","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1208\/s12249-011-9678-y","article-title":"Formulation and evaluation of in situ gelling Systems for Intranasal Administration of Gastrodin","volume":"12","author":"Cai","year":"2011","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijbiomac.2025.145987_bb0465","article-title":"In vitro and in vivo characterization of nasal pH-responsive in-situ hydrogel of candesartan-loaded invasomes as a potential stroke treatment","author":"El-Housiny","year":"2024","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ijbiomac.2025.145987_bb0470","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.addr.2009.08.004","article-title":"Chitosan-based formulations for delivery of DNA and siRNA","volume":"62","author":"Mao","year":"2010","journal-title":"Adv. Drug Deliv. Rev."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025065444?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025065444?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T14:36:58Z","timestamp":1762267018000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813025065444"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":94,"alternative-id":["S0141813025065444"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.145987","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A comprehensive review on natural polysaccharides based in situ gels for nasal drug delivery","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.145987","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"145987"}}